Nebulizers Market Is Expected to Reach USD 937.7 Million Globally in 2019
Transparency Market Research has published a new report titled "Nebulizers Market (Pneumatic Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019" to its report store.
Albany, NY -- (SBWire) -- 09/29/2014 --According to a new market research report published by Transparency Market Research (www.transparencymarketresearch.com) “Nebulizers Market (Pneumatic Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019” the global nebulizers market was valued at USD 610.0 million in 2012 and is estimated to reach a market worth of USD 937.7 million in 2019 growing at a CAGR of 6.5% from 2013 to 2019.
Browse the full report
A nebulizer is an electrically powered or battery operated instrument that converts liquid medication into mist or aerosol. Nebulizer is one of the preferred choices for the treatment of asthma, cystic fibrosis (CFTR) and COPD (chronic obstructive pulmonary disease). Increasing prevalence of various respiratory disorders such as asthma, COPD and CFTR coupled with rising geriatric population drives the growth of the nebulizers market globally. Moreover, increasing government initiatives also accounted for the market growth in the U.S., U.K and Japan.
Based on the product type nebulizers market is segmented as pneumatic nebulizer, ultrasonic nebulizer and mesh nebulizer. In 2012, pneumatic nebulizers accounted for the largest share of the global nebulizers market as these are cost effective as compared to ultrasonic and mesh nebulizers. However, slow medication delivery and low efficacy are some of the factors that might restrict the uptake of pneumatic nebulizers. Breath-actuated pneumatic nebulizer is the most promising type and accounted for the largest market share in the global market. Ultrasonic and mesh nebulizers provide efficient drug delivery compared to pneumatic nebulizers. However, high cost and drug inactivation during delivery might restrict the demand for these devices. Thus, large patient pool suffering from various chronic diseases such as asthma, COPD and cystic fibrosis increases the uptake of nebulizers globally.
On the basis of geography, the nebulizers market is segmented as North America, Europe, Asia-Pacific and Rest of the World (RoW). The global nebulizers market was valued at USD 610.0 million in 2012 and is expected to grow at a CAGR of 6.5% from 2013 to 2019, to reach an estimated value of USD 937.7 million by 2019. North America accounted for the largest market share for nebulizers globally in 2012 owing to highest number of asthma and COPD cases diagnosed in the world. For instance, the Centers for Disease Control and Prevention (CDC) published in 2012, that around 18.7 million adults in the U.S. were suffering from asthma. The American Lung Association states that COPD is the third leading cause of death in the U.S. every year. Thus, rising prevalence of various respiratory disorders such as asthma, cystic fibrosis and chronic obstructive pulmonary disease (COPD) propels the growth of the nebulizers market in North America. Europe accounted for the second largest share in the global nebulizers market in 2012. Large geriatric population base is one of the important factor driving the growth of nebulizers market in this region. Asia-Pacific is expected to grow at the highest CAGR from 2013 to 2019, due to increasing prevalence of asthma and bronchitis in this region. Additionally, companies are expecting large revenue with sufficient market penetration from Asia-Pacific region and thereby focusing on increasing investments in this region. For instance, in January 2013, Omron Healthcare, Inc. established a subsidiary in South Korea to sell devices for home and professional usage.
For further inquiries, ask here:
Major market players having presence in the global nebulizers market include Covidien plc (Puritan Bennett 740 Ventilator), GE Healthcare Ltd. (iVent201), Omron Healthcare, Inc. (NE C30), Philips Healthcare Ltd. (I-neb AAD System), PARI Respiratory Equipment Inc. (LC Sprint Reusable Nebulizer), GF Health Products, Inc. (iVent201), CareFusion Corporation (AirLife Misty Fast) and Allied Healthcare Products, Inc. (Schuco S6000 Air Compressor).
The global nebulizers market is segmented as follows:
Nebulizers Market, by Product Types
Vented Pneumatic Nebulizers
Breath-Actuated Pneumatic Nebulizers
Stand Alone Ultrasonic Nebulizers
Portable Ultrasonic Nebulizers
Static Mesh Nebulizers
Vibrating Mesh Nebulizers
Nebulizers Market, by Geography
Rest of The World
About Transparency Market Research
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR has experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
Ms. Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
USA/Canada Toll Free: 866-552-3453
Media Relations Contact
Transparency Market Research
View this press release online at: http://rwire.com/549386